Cintia Piccina

CIK: 0001907199

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AUTL

Autolus Therapeutics plc

Officer

ADAP

Adaptimmune Therapeutics PLC

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

AUTL
Autolus Therapeutics plc
Sep 2, 2026
Sale(S)
Direct
6.7K shares at avg. $2.34$16K
AUTL
Autolus Therapeutics plc
Sep 1, 2026
Exercise(M)
Direct
20K shares at avg. $2.35$47K
ADAP
Adaptimmune Therapeutics PLC
Feb 20, 2025
Award(A)
Option to purchase Ordinary Shares
Direct
1.6M shares-
ADAP
Adaptimmune Therapeutics PLC
Feb 20, 2025
Award(A)
Option to purchase Ordinary Shares
Direct
1.1M shares-
ADAP
Adaptimmune Therapeutics PLC
Jan 15, 2025
Sale(S)
Direct
13K shares at avg. $0.57$7K

		Type	Shares	Price		Ownership
Sep 2, 2026	AUTL Autolus Therapeutics plc	Sale(S)	6,713	$2.34	$15,682	Direct
Sep 1, 2026	AUTL Autolus Therapeutics plc	Exercise(M)	20,000	$2.35	$47,000	Direct
Feb 20, 2025	ADAP Adaptimmune Therapeutics PLC	Award(A) Option to purchase Ordinary Shares	1,612,032	-	-	Direct
Feb 20, 2025	ADAP Adaptimmune Therapeutics PLC	Award(A) Option to purchase Ordinary Shares	1,074,696	-	-	Direct
Jan 15, 2025	ADAP Adaptimmune Therapeutics PLC	Sale(S)	12,991	$0.57	$7,467	Direct

1-5 of 5 transactions

About Piccina Cintia

Piccina Cintia (SEC CIK 0001907199) files insider reports with the SEC as U.S. CCO & Country Gen Manager of Autolus Therapeutics plc (AUTL) and Chief Commercial Officer of Adaptimmune Therapeutics PLC (ADAP).

Signal8 holds 4 ownership filings by Piccina Cintia (1 Form 3, 3 Form 4), filed between Jan 15, 2025 and Sep 3, 2026. Those filings report 5 transactions, from Jan 15, 2025 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Piccina Cintia's filings is in LONDON.

Recent filings by Piccina Cintia

Sep 2, 2026: Open-market sale of AUTL shares (Form 4, code S).
Sep 1, 2026: Option exercise of AUTL shares (Form 4, code M).
Feb 20, 2025: Grants or awards of ADAP derivative securities (2 lines, Form 4, code A).
Jan 15, 2025: Open-market sale of ADAP shares (Form 4, code S).

Other insiders filing for Autolus Therapeutics plc (AUTL)

YOUNG WILLIAM D, Director
Rao Madduri Ravin, Director
Richardson Ryan, Director
Leiderman Elisabeth, Director
Iannone Robert, Director
BUTITTA CYNTHIA M, Director

How to read Form 4 transaction codes